Jennifer walked the length of the off-white sterile hallway and past scores of blue doors to the first of three crossroads. She turned right and walked into a construction zone. Three midsized HEPA filtration units and a pile of other boxes were sitting in the hallway outside the entrance to the brain chip department. The HEPA units were high-end systems designed to keep even the tiniest airborne particles from entering or leaving a sterile lab environment. She suspected that the intricate design of the brain chips required the air to be totally purified. She glanced in the open door as she passed. Rows of sophisticated machines were in the process of being moved. A researcher in a lab coat was involved in a heated discussion with one of the moving men. He was Chinese, slim with thick black hair and a long oval face. She recalled seeing him in the halls a couple of times, but they had never stopped to talk. His picture was on one of the staff memos, and it occurred to her that he was a department head, but she couldn’t remember which one. She continued down the hall, blue doors flashing by on both sides. At least her department was not in flux, she thought as she reached the doorway that gave access to the Alzheimer’s department. She had enough on her plate right now without her labs undergoing renovations. She swiped her card and entered the lab.

Veritas’s Alzheimer’s lab at White Oak was state of the art. Seven different and distinct labs were functioning as one, with each division having their own thrust at the problem. She had structured the labs that way, and the results to date were exceptional. Her staff members were in healthy competition with one another, approaching the disease from different directions but ultimately all with the same goal: to develop a drug to cripple the debilitating disease.

“Dr. Pearce,” a young woman said as she entered. “Thank goodness you’re here. Team Three is getting some really strange results. They want you to have a look.”

“Sure,” she said, slipping on a lab coat and entering the lab.

Two hours later she removed the coat, washed her hands, and left the building. The wonky results were a direct result of improper lab procedures. The samples had become contaminated, and it was the contaminants that had reacted to the enzyme. They had identified the guilty party and she had spoken with him-quietly, off to the side. There was no reason to go off the deep end-she just had to make sure it didn’t happen again.

As she reached her car, her mind went back to the thoughts of Kenga crashing over the cliff in the car, the driver somehow escaping. Things that didn’t add up. And things that were not subsiding into the far reaches of her memory. She couldn’t shake the idea that there was more to Kenga’s death than a simple automobile accident. Maybe she would take a detour on the way home and visit Kenga’s house.

Another look on Kenga’s home computer would dispel these crazy thoughts.

19

Kenga’s condo was dark as Jennifer pulled up in front. She switched off the car ignition and fingered the keys for a minute, wondering if she really wanted to know what was on the dead woman’s computer. What if these crazy suspicions she had were true? What then? If Veritas was killing its employees to keep them quiet, what could she do about it? And if they were, wouldn’t that put her next in the line of fire?

Jennifer sucked in a couple of deep breaths. What were the chances her suspicions would play out? Marginal to nil. She found Kenga’s key and held it tight between her thumb and index finger. As she exited the car, she glanced furtively up and down the street. Parked cars, a couple walking hand-in-hand, lights on in most of the houses. Nothing sinister. She walked quickly to the front door and let herself in. The cat poked his head out, saw it was her, and came over to rub against her leg.

“Oh, you poor thing,” she said, crouching and gently stroking the animal.“Your master isn’t coming home. You’re a nice cat- someone will want you.”

She straightened and walked directly to the bedroom Kenga had converted to a home office. She approached the desk and stopped. The computer was not as she had left it. Every time she left the office or shut down her home computer, she centered the mouse on the pad and laid a pen across the mouse pad at a forty-five-degree angle. It was a quirk of hers, but now she was glad she had done it. The pen was not on the mouse pad but beside it, on the desk. Someone had been in the house since her last visit on Wednesday.

She turned her attention to Kenga’s house. Was the intruder still somewhere inside? The house suddenly seemed darker, more sinister. She snapped on lights as she moved from room to room, checking the closets and under beds. A broom shifted when she yanked the door to the utility closet open, and she let out a short scream. She replaced the broom, feeling silly. The back door to the house was locked, all windows were closed, and the basement, which was unfinished, was empty. She returned to the small office, still on edge but confident no one else was in the house.

She powered up the computer and searched for the file with the Triaxcion data in it. Nothing. It was gone. She closed her eyes and let herself drift. One reason Jennifer Pearce was such a valuable researcher was her ability to envision chemical reactions without using paper or a computer screen. It was like playing a game of chess in her mind, without moving any of the pieces. She scrolled down slowly, line by line, her mind computing the formula, adjusting the molecules as the drug would once inside a human body. Finally, her brain overloaded and refused to store any more information. She squeezed her eyelids even tighter and let herself drift.

Triaxcion targeted testosterone, of that she was sure. It prohibited the conversion of the male hormone to dihydrotestosterone, enlarging the hair follicles in the subcutaneous layer of skin. This in turn kept the hair follicle intact and producing new growth. But, in her opinion, the chemical reaction inside the body would not be limited to the conversion process. This process involved the liver, as what she was looking at required the medicine to be broken down by liver enzymes. Furthermore, the dihydrotestosterone, once metabolized, immediately bound to albumin. But what would happen to the small percentage of DHT left unbound and wandering about the body? She wasn’t sure.

She was preparing to sign off when she remembered the file she had found embedded in the Triaxcion file. What was the name? She used her memory to replay opening the file. Slowly, the letters came into focus and she saw the name. Gordon Buchanan, Butte, Montana. She signed on to the Internet and keyed in a search for Butte Montana Buchanan. There were thousands of hits, but only one found all three keywords. There was an article in the Montana Standard with the name Buchanan, and she went to the paper’s Web site and opened it.

BUTTE-Tragedy struck the Twin Pines Sawmill on April 20, 2005, when Billy Buchanan died of injuries incurred while cutting a firebreak with a chain saw. According to witnesses, Buchanan was cutting a stump when the saw kicked back and sliced into his leg. Medically trained mill staff were on the scene and attended to Buchanan, but were unable to stop the bleeding. A helicopter, only minutes from the gorge where the accident occurred, rushed Buchanan to the hospital but he died en route.

The victim’s brother, Gordon Buchanan, is the owner of Twin Pines, and one of the primary employers in the Butte area. He was unavailable for comment.

The article went on to give some history on both brothers and their contributions to the local economy. Both men were apparently highly respected by everyone they interviewed. Gordon was painted as a highly successful businessman with strong ties to the community through his philanthropic gestures. Jennifer sent the page to Kenga’s printer and sat back in the chair.

From all appearances, someone had signed on to Kenga’s computer within the last twenty-four hours. But that was highly improbable. Kenga’s family was in Transylvania, and none of the other staff at Veritas had a key to her house-at least none that Jennifer knew about. And surely Kenga would have mentioned it if she had given another person a key. Two people both showing up at the same time and neither knowing the other had a key would be heart attack material. But considering that the Triaxcion file was missing, it didn’t take her Ph.D. to figure out who had been in the house.

Someone from Veritas.

But why? What in that file was so damaging to Veritas that they would break in and remove it from Kenga’s computer? Triaxcion was an FDA-approved drug, which meant the medication had passed Phase III trials and met regulatory standards. The chemical formula, which Veritas kept under lock and key, was patented and couldn’t be replicated by any of the generics. So even if another company managed to steal the formula, they couldn’t bring it to market without making substantial changes or fighting Veritas in a court of law. No, that angle didn’t make any

Вы читаете Lethal Dose
Добавить отзыв
ВСЕ ОТЗЫВЫ О КНИГЕ В ИЗБРАННОЕ

0

Вы можете отметить интересные вам фрагменты текста, которые будут доступны по уникальной ссылке в адресной строке браузера.

Отметить Добавить цитату